Cost-Effectiveness Analysis of Antimicrobial Prescribing in the Treatment of Clostridioides Difficile Infection in England

Bromilow, Tom; Holmes, Hayden; Coote, Laura; Woods, Sam; Pink, Joshua

doi:10.1007/s41669-023-00420-3

All Outputs (2)

Correction: Cost-Effectiveness Analysis of Antimicrobial Prescribing in the Treatment of Clostridioides Difficile Infection in England (2023)
Journal Article
Bromilow, T., Holmes, H., Coote, L., Woods, S., & Pink, J. (2023). Correction: Cost-Effectiveness Analysis of Antimicrobial Prescribing in the Treatment of Clostridioides Difficile Infection in England. PharmacoEconomics - Open, 7(5), 861-861. https://doi.org/10.1007/s41669-023-00434-x

Cost-Effectiveness Analysis of Antimicrobial Prescribing in the Treatment of Clostridioides Difficile Infection in England (2023)
Journal Article
Bromilow, T., Holmes, H., Coote, L., Woods, S., & Pink, J. (2023). Cost-Effectiveness Analysis of Antimicrobial Prescribing in the Treatment of Clostridioides Difficile Infection in England. PharmacoEconomics - Open, 7(5), 739-750. https://doi.org/10.1007/s41669-023-00420-3

Background: An economic model was developed with guidance from the National Institute for Health and Care Excellence (NICE) ‘Managing Common Infections’ (MCI) Committee to evaluate the cost effectiveness of different antibiotic treatment sequences fo... Read More about Cost-Effectiveness Analysis of Antimicrobial Prescribing in the Treatment of Clostridioides Difficile Infection in England.